You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Nerve Care (Neuropathy) Articles
Popular Nerve Care (Neuropathy) Articles
Highly Recommended Nerve Care (Neuropathy) Articles
Send a link to this page to your friends and colleagues.
However, the study results are not convincing enough to recommend LILT treatment for painful symptoms of DSP.
Fifty patients with painful DSP diagnosed with the Toronto Clinical Neuropathy Score were given either placebo or LILT therapy for four weeks after all patients received an initial two weeks of placebo treatment. The efficacy of the treatment was determined through pain scores on a visual analog scale.
LILT had no effect in such areas as sympathetic skin response or quantitative sensory testing or on the Toronto Clinical Neuropathy Score. Both groups noted a decrease in weekly average pain scores while they were receiving the placebo treatment.
After the four-week intervention, the group receiving LILT had an additional reduction in weekly average pain scores compared to the group on placebo treatment. The researchers conclude there was not sufficient evidence to support LILT as a treatment.
—Diabetes Care, April 2004
0 comments - Jun 1, 2004
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.